# Ezetimibe + Atorvastatin

## Atozet 10/20mg

| TAH Drug Code      | [OATOZ](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OATOZ)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Familial hypercholesterolemia. Hyperlipidemia， Primary. Mixed hyperlipidemia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | The recommended starting dose of Atozet is ezetimibe/atorvastatin 10/10-10/20 mg once daily. Could be administered at any time of the day with or without food.                                                                                                                                                                                                                                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Active liver disease or unexplained persistent elevations in hepatic transaminases. Breastfeeding. Women who are pregnant or may become pregnant. Hypersensitivity to ezetimibe， atorvastatin， or any component of the product.                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Common Gastrointestinal: Diarrhea (2.8% ) Musculoskeletal: Muscle weakness， Myalgia (3.6% ) Neurologic: Headache (5.8% ) Respiratory: Upper respiratory infection (3.6% ) Serious Dermatologic: Dermatomyositis， Subacute cutaneous lupus erythematosus Hepatic: Hepatitis， Increased liver enzymes (0.7% to 3.6% )， Jaundice， Liver failure Immunologic: Autoimmune disease Musculoskeletal: Autoimmune necrotizing myopathy， Statin-associated (Rare )， Disorder of muscle (0.2% )， Rhabdomyolysis (0.09% ) Respiratory: Bleeding from nose |
| Pregnancy          | Contraindicated – 1st Trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| More Info          | [UpToDate](https://www.uptodate.com/contents/ezetimibe-and-atorvastatin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

